420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
The Yale School of Medicine and CT Pharmaceuticals Solutions Inc. have teamed up to conduct a study on the impact of medical marijuana on stress and mental health. On Friday, Yale and CT Pharmaceuticals announced that they would be conducting a phase-one study on the effects of a variety of cannabis strains with medicinal qualities for alleviating pain and stress. They will also examine other conditions such as PTSD (post-traumatic stress disorder), and opioid replacement. This is a revolutionary clinical study which is the first of its kind to be approved by the state’s Department of Consumer Protection (DCP) medical marijuana research program to study stress and mental health, said Yale. The study on stress and mental health will advance CT Pharma’s current research which involves human subjects. CT Pharma’s current research was started in 2016 by Yale’s Dr. Rajita Sinha. In 2017, the Food and Drug Administration (FDA) gave Sinha in collaboration with the CT Pharma, a go-ahead for an Investigational New Drug application to examine how marijuana products affect subjective and physical responses to stress and pain. In a news release, Sinha said that there is an increase in the consumption of medical marijuana in America, and it…
Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : 420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
reposted by Cannabis News World
You must log in to post a comment.